Overview
Background
I am fascinated by the intricate and dynamic cellular processes that occur constantly within the human body. To understand this, my research amalgamates fields of molecular biology, mechanobiology, 3D models and multimodal quantitative live-cell microscopy. This amalgamation of the techniques permits insight into addressing challenging biological questions.
Availability
- Dr Robert Ju is:
- Available for supervision
Qualifications
- Bachelor of Biomedical Science, Queensland University of Technology
- Bachelor (Honours) of Biomedical Science, Queensland University of Technology
- Doctoral (Research) of Cell Biology, The University of Queensland
Works
Search Professor Robert Ju’s works on UQ eSpace
2019
Conference Publication
Bortezomib induces immunogenic cell death in melanoma and enhances immune responses in vivo
Daignault, S. M., Ju, R. J., Spoerri, L., Stehbens, S. J., Dolcetti, R. and Haass, N. K. (2019). Bortezomib induces immunogenic cell death in melanoma and enhances immune responses in vivo. 49th Annual Meeting of the European Society for Dermatological Research (ESDR), Bordeaux, France, 18-21 September, 2019. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2019.07.506
2019
Conference Publication
Enforcing cellular stress promotes apoptotic and immunogenic responses in melanoma
Daignault, S. M., Spoerri, L., Ju, R. J., Stehbens, S. J., Hill, D. S., Dolcetti, R. and Haass, N. (2019). Enforcing cellular stress promotes apoptotic and immunogenic responses in melanoma. 46th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Munich, Germany, 13-16 March 2019. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/exd.13859
2019
Conference Publication
Bortezomib-induced immunogenic cell death enhances immune response in melanoma
Daignault, S. M., Ju, R., Spoerri, L., Stehbens, S. J., Hill, D. S., Gabrielli, B., Dolcetti, R. and Haass, N. K. (2019). Bortezomib-induced immunogenic cell death enhances immune response in melanoma. Society for Investigative Dermatology (SID) Meeting, Chicago, IL United States, 8-11 May 2019. London, United Kingdom: Nature Publishing Group. doi: 10.1016/j.jid.2019.03.907
2018
Journal Article
Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer
Packer, Leisl M., Stehbens, Samantha J., Bonazzi, Vanessa F., Gunter, Jennifer H., Ju, Robert J., Ward, Micheal, Gartside, Michael G., Byron, Sara A. and Pollock, Pamela M. (2018). Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer. Molecular Oncology, 13 (4), 738-756. doi: 10.1002/1878-0261.12422
2018
Journal Article
The role of melanoma cell-stroma interaction in cell motility, invasion, and metastasis
Ju, Robert J., Stehbens, Samantha J. and Haass, Nikolas K. (2018). The role of melanoma cell-stroma interaction in cell motility, invasion, and metastasis. Frontiers in Medicine, 5 (NOV) 307, 1-9. doi: 10.3389/fmed.2018.00307
2018
Journal Article
FGFR2b activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer
Stehbens, Samantha J., Ju, Robert J., Adams, Mark N., Perry, Samuel, Haass, Nikolas K., Bryant, David M. and Pollock, Pamela M. (2018). FGFR2b activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer. Journal of Cell Science, 131 (15) jcs.213678, 1-16. doi: 10.1242/jcs.213678
2017
Journal Article
PI3K inhibitors synergize with FGFR inhibitors to enhance antitumor responses in FGFR2mutant endometrial cancers
Packer, Leisl M., Geng, Xinyan, Bonazzi, Vanessa F., Ju, Robert J., Mahon, Clare E., Cummings, Margaret C., Stephenson, Sally-Anne and Pollock, Pamela M. (2017). PI3K inhibitors synergize with FGFR inhibitors to enhance antitumor responses in FGFR2mutant endometrial cancers. Molecular Cancer Therapeutics, 16 (4), 637-648. doi: 10.1158/1535-7163.MCT-16-0415
2016
Journal Article
Combination of BGJ398 with either a pan-PI3K inhibitor or a specific PIK3CA inhibitor shows synergy in FGFR2 mutant endometrial cancer cell lines
Packer, L., Geng, X., Bonazzi, V., Mahon, C., Ju, R., Stephenson, S. and Pollock, P. (2016). Combination of BGJ398 with either a pan-PI3K inhibitor or a specific PIK3CA inhibitor shows synergy in FGFR2 mutant endometrial cancer cell lines. European Journal of Cancer, 61, S148. doi: 10.1016/s0959-8049(16)61523-x
Supervision
Availability
- Dr Robert Ju is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Available projects
-
Mechanobiology and Molecular Drivers of Colon Cancer in 3D Organoid Models
This PhD project will use advanced 3D organoid models, molecular engineering, and quantitative live-cell microscopy to uncover how mechanical and molecular cues drive colon cancer initiation, growth, and progression.
Supervision history
Completed supervision
-
2025
Doctor Philosophy
The Role of Mitochondrial Morphodynamics In Confined Migration
Associate Advisor
Other advisors: Associate Professor Julia Pagan, Associate Professor Samantha Stehbens
Media
Enquiries
For media enquiries about Dr Robert Ju's areas of expertise, story ideas and help finding experts, contact our Media team: